Latest Product News
New dPCR Liquid Biopsy Assays for QuantStudio Absolute Q dPCR System and Custom Design Tool Simplify Cancer Research
Thermo Fisher Scientific has introduced over 50 new Absolute Q Liquid Biopsy Assays to run on the Applied Biosystems QuantStudio Absolute Q dPCR System.
Personalis and UCSF To Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer
Personalis has announced a collaboration with UC San Francisco that will deploy a personalized liquid biopsy-based research use only assay for a study of patients with colorectal cancer.
Nautilus Biotechnology Launches “First Access Challenge”
Open competition allows researchers to be among the first to access potentially groundbreaking proteomic data through the testing of twelve samples on Nautilus’ single-molecule protein analysis platform.
Mainz Biomed Announces US Extension of ColoFuture Study To Evaluate Integration of Novel mRNA Biomarkers Into ColoAlert
Mainz Biomed has announced the initiation of eAArly DETECT, its US extension of ColoFuture, which is the Company’s European feasibility study evaluating the integration of a portfolio of novel gene expression (mRNA) biomarkers into ColoAlert.
Actym Therapeutics Reports Preclinical Data Demonstrating ACTM-838’s Ability To Generate Anti-Tumor Immunity
Actym Therapeutics has announced that an abstract highlighting detailed preclinical data of its lead candidate, ACTM-838, was accepted for presentation at the Society for Immunotherapy of Cancer 37th Annual Meeting.
OncoHost To Present Proteomics-Based Biomarker Model for Clinical Benefit to Immunotherapy in NSCLC Patients at SITC 2022
OncoHost has developed a novel predictive model for clinical benefit of immune checkpoint inhibitor in non-small cell lung cancer patients.
Arima Genomics Presents Data on Cancer Structural Variants at the Association of Molecular Pathology Annual Meeting
Arima Genomics, Inc. has announced that new data on the detection of actionable structural variants from cancer samples embedded in formalin-fixed, paraffin-embedded tissues will be presented at the Association of Molecular Pathology Annual Meeting.
Medical Device Innovation Consortium Partners With PerkinElmer's Horizon Discovery To Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics
The Medical Device Innovation Consortium has partnered with PerkinElmer's Horizon Discovery to develop and manufacture somatic reference samples to simplify and support the validation of next-generation sequencing-based cancer diagnostics.
INTEGRA’s Automated Pipetting Solutions Improve Accuracy and Reproducibility for MicroRNA-Based Diagnostics
MiRXES, a biotechnology company based in Singapore, is relying on a range of INTEGRA pipetting systems to increase the speed and precision of its RT-qPCR workflows.
SonALAsense Forges Ahead With First Patient Dosing for Devastating Childhood Brain Cancer
Multisite study will test sonodynamic therapy in pediatric patients with diffuse intrinsic pontine glioma (DIPG).